Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of aripiprazole versus risperidone in attention deficit hyperactivity disorder
IRCT2013050413215N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aripiprazole and risperidone in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Feb 2012; status: completed.
02
Drugs
aripiprazolerisperidone
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT2013050413215N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013050413215N1.